Member Info for doggo

Wouldn’t worry about the day to day SP, clearly not enough volume to move this north currently, so it’s at the mercy of the 10% brigade. News will be a constant soon enough. Those who know what’s coming within the investee companies just need to sit tight and watch the Mellon show that’s about to start.

Yooya largest shareholders have announced regarding their Venture Capital sector “expect sale of several companies via IPO or trade sale”

They may well sell their Intensity shares & options to Portage at a very healthy premium (in return for portage shares)

The fact that SALV(majority owned by Mellon and Bailey) are being bought by a Canadian company that are 40% owned by Mellon and Bailey and will be holding 60% after the deal goes through should be a signal to anyone looking at Ffwd. The $5million options in intensity that are going to be bought by institutional buyers could be worth a monster amount when they announce the news they are obviously sitting on..

Peter Saladino holds ~10% of FFWD at an average of 17.6p also an advisor for CeresCoin. PS isn’t here to take a loss

It’s a certainty to be sold near term. IMG holding company acquire companies and take everything in-house. £20 million may be a decent starting bid Steve..

Have a look at the gambling brands that GVC own: BWIN,party poker, Ladbrokes, coral, sporting bet, betdaq etc far too many for me to be bothered to list, have also just signed a JV with MGM in the States. Add that to this..GVC Holdings has extended its supply deal with virtual sports specialist Leap Gaming to launch a number of new titles from the software provider, including its new in-play virtuals titles. The contract extension will see GVC continue to offer Leap’s content via its flagship gaming sites such as bwin and partycasino, bolstering the portfolio with the addition of in-play tennis and football, on-demand virtual sports and scheduled racing events. “We are delighted to build on our partnership with Leap Gaming in a deal which demonstrates our commitment to continuously offer new products to our customers,” GVC chief product officer Liron Snir said. “In-play is a critical feature for real-life sports betting and we have every confidence that it will be a popular element in virtuals, while on-demand is another great innovation that will enable our users to define their own event schedule. “To cap it all, Leap’s virtuals feature outstanding graphics and state-of-the-art UX which substantially improve the user experience.” Add that to FFWD owning 45% of Leap.. Leap would hardly get into any LTHs top 3 investee companies within the FFWD PF....13p you are having a laugh

The post raise valuation of FACTOM could be eye-wateringly massive. I’ll put it out there now that our factom % will be valued at far higher than our current MCAP.

You people don’t discuss the investee companies. Anyone looking in may decide to sell or hold or even buy if you treat the room like a information portal rather than a chat about anything other than what FFWD are invested in

Finished too much news incoming

Very soon...

Very confident we have reached the bottom. Ponder the following that are all upcoming ... Intensity options news Intensity series B news Factom series B (people could be in for a huge shock when they see who is leading the round) Yooya IPO or sale news Leap sale The new cannabis play via Saladino(this is a monster) Vogogo 3rd Q results Juvenescence IPO We have lots of ex-holders who are following the story closely all trying to catch the bottom. Aphria money to return etc All very exciting and will move very quickly when everyone wants back in at the same time..the beauty of the PF is news won’t drop during U.K. trading hours as most are North American based and people will be forced to read the news and will all try to buy in one sunny morning. As long as you are all holding what you want to be holding then you can watch it all unfold.

Not me selling Predator I know more about the PF than anybody else

Price action will happen hen we get news. But when news (major news) lands you won’t be able to buy at anywhere near the current price. What the likes of Matador, wad, myself do is post portfolio news that is unknown or new to the majority of readers.
We hope to persuade a few to buy a few, a few to hold for a day or more (long term for most people on aim appears to be an underpant change period of time).

How do people imagine portage will get their minority SH to vote though a deal at 250% premium without Salv knowing that big news is imminent re intensity

That’s a classic sign of a paid deramper same message again and again..lol

Portage Biotech and Boehringer Ingelheim Venture Fund participated in a Series A round that, in combination with non-dilutive funding from the National Institute of Health will allow Sentien to finish IND enabling studies and proceed to a Phase I trial in patients. A successful Phase I trial would significantly affect the valuation and could trigger a liquidity event.....
Free to SALV holders

Advertising for a Director of Manufacturing - The Director will develop a team to drive process engineering for future manufacturing needs through late-stage clinical trials and US commercialization. This requires tight collaborations with R&D, Quality and Regulatory to improve upon existing process and implement next-generation manufacturing.

Watch the video

vimeo.com/188019015

We get a share of this when Portage takeover SALV

Intensity Therapeutics have just tweeted for the first time in 9 months ....

Our drug INT230-6 was designed specifically to treat pancreatic cancer.